Clinical Trials Sponsored by ResMed Foundation

Total 16578 results

ResMed
Lymphatic Solutions, LLC

Completed

A Preference Study of Two Pneumatic Compression Devices for Patients With Lower Limb Lymphedema

Lymphedema | Lymphedema, Secondary | Lymphedema, Lower Limb | Lymphedema of Leg | Lymphedema Primary

United States
Massachusetts General Hospital
ResMed

Completed

Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients

Copd | COPD Exacerbation

United States
McGill University
ResMed; VitalAire

Unknown

Obstructive Sleep Apnea, CPAP Treatment & Cognitive Ability in HIV

Obstructive Sleep Apnea | Cognitive Change | Hiv

Canada
Conde, Bebiana, M.D.
ResMed

Unknown

TELE-monitoring in Chronic Obstructive Pulmonary Disease (TELECOPD)

COPD

Portugal
University of Oslo
ResMed

Completed

Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-study) (3C)

Heart Failure | Cheyne Stokes Respiration

Norway
Skaraborg Hospital
The Swedish Research Council; Swedish Heart Lung Foundation; ResMed Foundation; Heart Foundation of Karnsjukhuset Sweden

Completed

Continuous Positive Airway Pressure (CPAP) Treatment in Coronary Artery Disease and Sleep Apnea (RICCADSA)

Coronary Artery Disease | Obstructive Sleep Apnea

Sweden
ResMed
RWTH Aachen University

Active, not recruiting

Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP (TelePAP)

Obstructive Sleep Apnea | Central Sleep Apnea | Mixed Sleep Apnea

Germany
The Cleveland Clinic
ResMed

Active, not recruiting

SAMPAP Trial -Impact of a Novel Sleep Apnea Management Group Intervention on Positive Airway Pressure Adherence

Sleep Apnea

United States
ResMed
University Hospital, Essen

Completed

Adjustment of Mask Pressure, for Bilevel Positive Airways Pressure Therapy, by Automated Algorithm

Respiratory Insufficiency | Sleep Disordered Breathing

Germany
ResMed
St George Hospital, Australia

Completed

Portable Oxygen Concentrator Signal Capture Study

Hypoxia

Australia
Medical College of Wisconsin
ResMed

Completed

Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea

Sleep Apnea | Sleep Disordered Breathing

United States
Schön Klinik Berchtesgadener Land
ResMed

Terminated

Effects of Non-invasive Ventilation on Rehabilitation Outcome in COPD-patients

Chronic Obstructive Pulmonary Disease

Germany
University Hospital, Grenoble
ResMed; VitalAire

Completed

Prevalence of Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients Treated With Insulin Pump (At1Home) (AT1Home)

Type 1 Diabetes

France
Schön Klinik Berchtesgadener Land
ResMed

Completed

The Effect of Non-invasive Ventilation on the Oxygenation of Peripheral Muscle in Hypercapnic COPD Patients

COPD | Hypercapnia

Germany
Schön Klinik Berchtesgadener Land
ResMed

Completed

Effects of Different Oxygen Devices in Hypoxemic COPD Patients

Chronic Obstructive Pulmonary Disease Severe

Germany
University of Coimbra
Compassionate Mind Foundation; Reed Foundation

Completed

Feasibility and Effectiveness Study of a Compassionate Mind Training Program for Teachers (COMP-S)

Teachers

Portugal
ResMed
SleepScore Labs International LTD

Recruiting

The Effects of a Personalized Sleep Improvement App From SleepScore Labs

Health Behavior

Germany
Centre Hospitalier de Valence
ResMed

Completed

How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement (OAMMM)

Respiratory Tract Diseases | Sleep Apnea Syndromes | Sleep Apnea, Obstructive

France
St Vincent's University Hospital, Ireland
ResMed

Suspended

Adaptive Servo Ventilation (ASV) in Heart Failure

Acute Decompensated Heart Failure | Sleep Disordered Breathing

Ireland
ResMed
The University of Western Australia

Completed

AutoSet for Her Clinical Trial Protocol

Obstructive Sleep Apnea

Australia
Remedy
Remedy Institute

Recruiting

MDMA-Assisted CBCT for PTSD vs CBCT RCT

Post Traumatic Stress Disorder

Canada
Albert Einstein Healthcare Network
Resmed Inc

Completed

Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea. (ASAP-HF)

Heart Failure | Sleep Apnea, Obstructive | Hypertension, Pulmonary

United States, Germany
ResMed
CRI-The Clinical Research Institute GmbH

Recruiting

HomeVent ( Connect) Registry: EU COPD Home NIV Registry (HOmeVent)

Chronic Obstructive Pulmonary Disease

Germany
ResMed
CRI-The Clinical Research Institute GmbH

Completed

Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure (Serve-HF)

Heart Failure | Sleep Disordered Breathing

Germany, Netherlands, Australia, Denmark, France, United Kingdom, Switzerland, Norway, Finland, Sweden, Czechia
Institut für Pneumologie Hagen Ambrock eV
ResMed

Completed

Intelligent Volume Assured Pressure Support to Improve Sleep Quality and Respiratory Events in Patients With Non Invasive Ventilation

COPD | Chronic Hypercapnic Respiratory Failure

Germany
University Hospital, Grenoble
ResMed; AGIR à Dom

Terminated

Innovation in NOn Invasive Ventilation in COPD Patients Treated by Long Term Oxygen Therapy (INOV-LTOT)

Chronic Obstructive Pulmonary Disease

France
Prof. Claudio Bassetti
Swiss National Science Foundation; ResMed; Philips Respironics; Schweizerische...

Unknown

Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy (SAS-CARE)

Ischemic Stroke | TIA

Germany, Italy, Switzerland
Insmed Incorporated

Completed

A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

Pulmonary Hypertension

Belgium, Germany, Spain, Argentina, Australia, Italy, United Kingdom
Insmed Incorporated

Completed

Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

Cystic Fibrosis
Insmed Incorporated

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants

Healthy Volunteers

United States
Insmed Incorporated

Completed

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

Healthy Volunteers
Insmed Incorporated

Completed

Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Cystic Fibrosis

Poland, Ukraine, Serbia, Belgium, Hungary, Slovakia, North Macedonia
Insmed Incorporated

Completed

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

Pseudomonas Aeruginosa Infection

France, Poland, United Kingdom, Germany, Spain, Belgium, Bulgaria, Denmark, Greece, Canada, Netherlands, Hungary, Italy, Ireland, Sweden, Slovakia, Austria, Serbia
DreaMed Diabetes

Unknown

Observational, Data Collection Study for Subjects With Diabetes Using Insulin Injections

Diabetes Mellitus

Israel
Insmed Incorporated

Completed

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Cystic Fibrosis

United States
Rehamed Center

Unknown

Clinical Efficacy of Luna EMG Robot Therapy for Patients After Stroke

Stroke
Insmed Incorporated

Completed

Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung

Osteosarcoma Metastatic

United States
RenaMed Biologics

Terminated

Study to Evaluate the Safety and Efficacy of the Renal Assist Device in Patients With Acute Renal Failure

Kidney Failure, Acute

United States
Insmed Incorporated

Recruiting

A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) (BiRCh)

Chronic Rhinosinusitis Without Nasal Polyps

United States, Australia, Argentina, Canada, Bulgaria, Poland, Portugal, Czechia, France, Italy, Spain
Insmed Incorporated

Recruiting

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

Argentina, Austria, Brazil, Germany, Italy, Malaysia, Philippines, Spain, United Kingdom, Serbia, Japan, United States, Mexico, Denmark
Insmed Incorporated

Recruiting

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Pulmonary Hypertension | Interstitial Lung Disease

Belgium, Germany, Spain, Italy, Argentina, Australia, United Kingdom
Insmed Incorporated

Recruiting

Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex (ENCORE)

Mycobacterium Infections, Nontuberculous

Belgium, New Zealand, United Kingdom, United States, Argentina, Australia, Austria, Canada, Chile, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Poland, Spain, Taiwan, Turkey, Portugal
Insmed Incorporated

Completed

A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants (INS1007)

Healthy Participants

United States
Restem, LLC.

Completed

Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS (ULSC)

Covid19 | Corona Virus Infection | ARDS | SARS-CoV Infection | Coronavirus

United States
Insmed Incorporated

Terminated

A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States
Insmed Incorporated

Completed

A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants

Healthy Volunteers

United States
Insmed Incorporated

Completed

A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Hepatic Impairment

United States
Insmed Incorporated

Completed

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants

Healthy Volunteers

United States
Insmed Incorporated

Completed

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex (ARISE)

Mycobacterium Infections, Nontuberculous

United States, Argentina, Australia, Austria, Canada, Chile, Denmark, Germany, Israel, Italy, Korea, Republic of, New Zealand, Spain, Taiwan
Insmed Incorporated

Completed

A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

Renal Impairment

United States

Clinical Trials Sponsored by ResMed Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations